Health-related quality of life outcomes in patients with moderate to severe psoriasis treated with ABT-874 versus etanercept or placebo

被引：0
|
作者：
Menter, Alan [1 ]
Signorovitch, James [2 ]
Sundaram, Murali [3 ]
Bao, Yanjun [3 ]
机构：
[1] Baylor Psoriasis Res Inst, Dallas, TX USA
[2] Anal Grp, Boston, MA USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2011年 / 64卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB160 / AB160
页数：1
相关论文
共 50 条
  • [31] Ustekinumab improves disease specific health-related quality of life in patients with moderate to severe psoriasis: Results with the dermatology life quality index
    Lebwohl, M.
    Papp, K.
    Schenkel, B.
    Eisenberg, D.
    Yeilding, N.
    Guzzo, C.
    Wang, Y.
    Li, S.
    Krueger, G. G.
    VALUE IN HEALTH, 2008, 11 (03) : A293 - A293
  • [32] Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing
    Gracia-Cazana, Tamara
    Bernal-Masferrer, Laura
    Morales-Callaghan, Ana Maria
    Almenara-Blasco, Manuel
    Gilaberte, Yolanda
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 221 - 229
  • [33] Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis
    Chung, Jina
    Duffin, Kristina Callis
    Takeshita, Junko
    Shin, Daniel B.
    Krueger, Gerald G.
    Robertson, Andrew D.
    Troxel, Andrea B.
    Van Voorhees, Abby S.
    Edson-Heredia, Emily
    Gelfand, Joel M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (04) : 623 - 632
  • [34] Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis
    Kimball, Alexa B.
    Gordon, Kenneth B.
    Langley, Richard G.
    Menter, Alan
    Chartash, Elliot K.
    Valdes, Joaquin
    ARCHIVES OF DERMATOLOGY, 2008, 144 (02) : 200 - 207
  • [35] Etanercept Improves Quality of Life Outcomes and Treatment Satisfaction in Patients with Moderate to Severe Plaque Psoriasis in Clinical Practice
    Vender, Ron
    Lynde, Charles
    Gilbert, Martin
    Ho, Vincent
    Sapra, Sheetal
    Poulin-Costello, Melanie
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2012, 16 (06) : 407 - 416
  • [36] Efficacy, safety and health-related quality of life of infliximab therapy in plaque psoriasis patients previously treated with etanercept: analysis of PSUNRISE
    Gottlieb, A. B.
    Kalb, R. E.
    Blauvelt, A.
    Heffernan, M. P.
    Sofen, H.
    Wang, J.
    Calabro, S.
    Kerkmann, U.
    Chevrier, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 23 - 23
  • [37] The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis
    Frieder, Jillian
    Kivelevitch, Dario
    Fiore, Connie Tran
    Saad, Saadeddine
    Menter, Alan
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (01) : 1 - 19
  • [38] Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases
    James W. Varni
    Denise R. Globe
    Shravanthi R. Gandra
    David J. Harrison
    Michele Hooper
    Scott Baumgartner
    European Journal of Pediatrics, 2012, 171 : 485 - 492
  • [39] Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases
    Varni, James W.
    Globe, Denise R.
    Gandra, Shravanthi R.
    Harrison, David J.
    Hooper, Michele
    Baumgartner, Scott
    EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (03) : 485 - 492
  • [40] Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy
    Portela, Francisco
    Ministro, Paula
    De Deus, Joao
    Cravo, Marilia
    Cotter, Jose
    Duque, Gabriela
    Ferreira, Frederico
    Rosa, Bruno
    Ferreira, Pedro Lopez
    Dias, Claudia Camila
    Magro, Fernando
    DIGESTION, 2020, 101 (05) : 631 - 637
12345